-
1.发明公开
公开(公告)号：EP1841738A2
公开(公告)日：2007-10-10
申请号：EP05858534.0
申请日：2005-07-26
申请人： Athersys, Inc.
IPC分类号： C07D209/80 , C07D209/56
CPC分类号： C07D209/90 , A61K31/403 , C07D209/70 , C07D409/04 , C07D491/04
摘要： The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are tricyclic indeno-pyrrole compounds. These compounds are serotonin receptor (5-HT) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT) is desired (e.g. anxiety, depression and obesity).
-
2.发明公开TRICYCLIC HETEROARYL PIPERAZINES, PYRROLIDINES AND AZETIDINES AS SEROTONIN RECEPTOR MODULATORS 有权三环杂芳哌嗪，吡咯烷和氮杂环丁烷血清素受体调节剂
公开(公告)号：EP1796663A2
公开(公告)日：2007-06-20
申请号：EP05794345.8
申请日：2005-09-01
申请人： Athersys, Inc.
IPC分类号： A61K31/407 , C07D495/02
CPC分类号： C07D491/04 , C07D495/04
摘要： The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are hexahydroazepinoindole and octahydroazepinoindole compounds. These compounds are serotonin receptor (5-HT) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT) is desired (e.g. anxiety, depression and obesity).
-
公开(公告)号：EP1778243B1
公开(公告)日：2012-10-31
申请号：EP05789932.0
申请日：2005-06-29
申请人： Athersys, Inc.
发明人： BENNANI, Youssef, L. , ROBARGE, Michael, J. , BOM, David C. , VARGA, Norbert , TUMEY, Lawrence, N.
IPC分类号： C07D495/04 , A61K31/55 , A61P25/00
CPC分类号： C07D495/04
-
公开(公告)号：EP1778243A2
公开(公告)日：2007-05-02
申请号：EP05789932.0
申请日：2005-06-29
申请人： Athersys, Inc.
发明人： BENNANI, Youssef, L. , ROBARGE, Michael, J. , BOM, David C. , VARGA, Norbert , TUMEY, Lawrence, N.
IPC分类号： A61K31/55 , C07D487/00 , A61P25/00 , C07D233/00
CPC分类号： C07D495/04
摘要： The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are hexahydroazepinoindole and octahydroazepinoindole compounds. These compounds are serotonin receptor (5-HT) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT) is desired (e.g. anxiety, depression and obesity).
-
5.发明授权TRICYCLIC HETEROARYL PIPERAZINES, PYRROLIDINES AND AZETIDINES AS SEROTONIN RECEPTOR MODULATORS 有权三环杂芳哌嗪，吡咯烷和氮杂环丁烷血清素受体调节剂
公开(公告)号：EP1796663B1
公开(公告)日：2011-05-04
申请号：EP05794345.8
申请日：2005-09-01
申请人： Athersys, Inc.
IPC分类号： A61K31/407 , C07D495/02 , A61K31/4365 , A61P25/00
CPC分类号： C07D491/04 , C07D495/04
摘要： The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are hexahydroazepinoindole and octahydroazepinoindole compounds. These compounds are serotonin receptor (5-HT) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT) is desired (e.g. anxiety, depression and obesity).
-
6.发明公开THIOPHENYL AND PYRROLYL AZEPINES AS SEROTONIN 5-HT2C RECEPTOR LIGANDS AND USES THEREOF 有权THIOPHENYLAZEPINE作为配体的5-羟色胺5-HT 2C受体和用途
公开(公告)号：EP1981337A2
公开(公告)日：2008-10-22
申请号：EP07718077.6
申请日：2007-01-17
申请人： Athersys, Inc.
CPC分类号： C07D495/04 , C07D495/06
摘要： The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention, are thiophenyl and pyrrolyl azepine compounds. These compounds are serotonin receptor (5- HT2c) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT20) is desired (e.g. addiction, anxiety, depression, obesity, and others).
-
7.发明授权THIOPHENYL AZEPINES AS SEROTONIN 5-HT2C RECEPTOR LIGANDS AND USES THEREOF 有权THIOPHENYLAZEPINE作为配体的5-羟色胺5-HT 2C受体和用途
公开(公告)号：EP1981337B1
公开(公告)日：2015-09-02
申请号：EP07718077.6
申请日：2007-01-17
申请人： Athersys, Inc.
IPC分类号： A01N43/00 , A61K31/55 , A61K31/00 , C07D495/04 , C07D495/06
CPC分类号： C07D495/04 , C07D495/06
-
-
-
-
-
-
搜索结果
7 条记录 (耗时 0.012 秒)
